Navigation Links
Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida

MOORESVILLE, N.C., July 30 /PRNewswire-FirstCall/ -- Anpath Group, Inc. (OTC Bulletin Board: ANPG), reported today that its wholly owned subsidiary, EnviroSystems, Inc. (ESI) announced that its EnviroTru(R) disinfectant has been assigned a commodity code through the Department of Management Services (DMS) in the State of Florida. The Company reported that its distributor, A World of Green, LLC(TM) ( ) worked with the DMS to have EnviroTru(R) assigned under the code which now permits State and local facilities to purchase EnviroTru(R). A World of Green, a Florida-based company is focused on human-safe, earth-friendly cleaning products and services for commercial and residential use.

The Company reported that as a result of the EnviroTru(R) commodity code assignment, A World of Green immediately received orders from several Florida state facilities. The ESI distributor expects to place the product with numerous other Florida state agencies in the near future.

EnviroTru(R) is a multi-purpose disinfectant, sanitizer and deodorizing cleaner, effective against numerous organisms, including MRSA. EnviroTru(R) is registered by the Environmental Protection Agency (EPA) and meets EPA requirements for Toxicity Category IV (minimal effects noted, no precautionary or first aid statements required.). EnviroTru(R) has no special handling requirements, does not require protective clothing, gloves or special ventilation and is non-flammable. It also conforms to AMS 1452A, AMS 1453 and Boeing D6-7127 specifications for non-corrosion and materials compatibility.

Colleen Byrnes, Partner and Director of Marketing for A World of Green(TM) commented, "Assignment of a commodity code to EnviroTru(R) by the state of Florida is another validation of both our company's mission and that of EnviroSystems. We are convinced that the ESI technology, as evidenced by EnviroTru(R), satisfies the significant need to provide cleaners, sanitizers and disinfectants that eliminate disease-causing microorganisms like MRSA while protecting equipment, the public and the environment. The decision to approve EnviroTru(R) also points to Florida's commitment to protect its citizens and visitors in an environmentally responsible fashion."

According to Jeff Savino, Vice President, Sales & Marketing for EnviroSystems, Inc., "EnviroTru(R) is now part of a Florida state initiative, MyFloridaMarketplace (MFMP) , established over 5 years ago as an online purchasing exchange. MFMP offers a number of benefits for both buyers and vendors, including faster order processing through automated transactions, contracts and approvals resulting in reduction of time from requisition to payment. To date MFMP has 29 Florida agencies using the system and has processed over 587,000 purchase orders totaling more than $5 billion. It is a very effective tool for delivering our products to the state."

About Anpath Group, Incorporated:

Anpath Group, Inc., through its wholly owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment or the environment. Visit for more information.

EnviroSystems, Inc. is focused on safe infection prevention technologies that the company believes will position the company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks -- both natural and man-made.

Forward-Looking Statements:

This release contains forward-looking statements, which reflect expectation or belief by Anpath Group, Inc. concerning future events that involve risks and uncertainties. Anpath Group can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Anpath Group expectations, including, but not limited to EPA and state registration of the Company's products, the Company's ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development of its technology, the risk that products may not result from development activities, protection of its intellectual property, need for regulatory approvals, and other factors discussed in periodic Anpath Group, Inc. filings with the Securities and Exchange Commission. Forward-looking statements are qualified in their entirety by the above cautionary statement. Anpath Group assumes no duty to update its outlook or other forward-looking statements as of any future date.

SOURCE Anpath Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
2. Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:12/1/2015)... MARIETTA, Ga. , Dec. 1, 2015 ... purchase Dallas, Texas -based Tenet Healthcare,s ... WellStar Board of Trustees approved the strategic move following ... expand upon its proven clinical care models and patient ... improved access to healthcare to new communities. ...
(Date:12/1/2015)...  Eyeon Therapeutics has received a Notice of ... on a charged hydrophilic polymer developed at Particles ... has been shown to be safe and effective ... Mitchnick , MD, CEO states, "This second set ... in conjunction with a therapeutic agent.  Nanoparticles coated ...
(Date:12/1/2015)... Pharma Tech Outlook recently conducted a comprehensive ... Management Solution Providers - 2015 .  After careful consideration ... CIOs, VCs, analysts, and the Pharma Tech Outlook editorial ... 10 clinical data management solution providers (check out the ... 36 respectively). --> ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates mobile ... wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they are ... of North America (RSNA) 2015 annual meeting through December 3 in Chicago, Illinois, ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... that it has been selected as a finalist in this year’s Fierce Innovation ... FierceMobileHealthcare. Next IT Healthcare was recognized as a finalist in the category of ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest ... Integration ,” addresses a main “pain point” for merging or aligning healthcare provider ... a deal is signed. This quick-read guidance suggests that failing to recognize ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , ... membership and leadership since 2008. Gary Bruce, President of PartnerTech North America, currently ... spent a significant amount of time in Sweden since joining PartnerTech based in ...
Breaking Medicine News(10 mins):